Transcription factor (TF) networks are a key determinant of cell fate decisions in mammalian 2 development and adult tissue homeostasis, and are frequently corrupted in disease. However, our 3 inability to experimentally resolve and interrogate the complexity of mammalian TF networks has 4 hampered the progress in this field. Recent technological advances, in particular large-scale 5 genome-wide approaches, single-cell methodologies, live-cell imaging, and genome editing, are 6 emerging as important technologies in TF network biology. Several recent studies even suggest a 7 need to re-evaluate established models of mammalian TF networks. Here, we provide a brief 8 overview of current and emerging methods to define mammalian TF networks. We also discuss how 9 these emerging technologies facilitate new ways to interrogate complex TF networks, consider the 10 current open questions in the field, and potential future directions and biomedical applications. 
Introduction 1
During mammalian development, hundreds of unique cell types are specified in a complex spatio-2 temporal patterning process. In adults, stem and progenitor cell populations replenish mature cell 3 types to maintain tissue homeostasis throughout life. Concerted gene expression programs are 4 responsible for these fundamental biological processes and the underlying cell fate decisions. 5
Transcription represents a major control point in gene expression ( Figure 1A) and occurs within the 6 context of chromatin. Precise spatial and temporal expression of combinations of a limited number 7 of genes (~20,000 in humans) appears to be responsible for the intricate cellular processes of 8 developmental specification and adult tissue homeostasis. 9
10
Sequence-specific transcription factors (TFs) are a large class of DNA binding protein that play 11 central roles in regulating gene transcription, and account for almost 7% of genes (~1,400) in the 12 human genome (Vaquerizas et al., 2009 ). TFs regulate gene promoter activity, but often act via 13 interactions with other genomic locations that can be distant in primary DNA sequence. These are 14 broadly defined as gene regulatory regions (Kellis et al., 2014) , with an important subclass of 15 positive regulatory regions being termed enhancers. Enhancers are composed of TF binding sites 16 (TFBSs) or DNA motifs, which are are commonly short (4-12 nucleotides) (Jolma et al., 2013) . 17
Such motifs therefore frequently occur by chance in mammalian genomes and individual TF-DNA 18 interactions can be weak. TF-DNA interactions must compete with histone-DNA interactions for 19 stable and productive binding. Cooperativity in TF binding is therefore common, such as through 20
protein-protein interactions with other TFs, co-activators, and/or co-repressors (Vaquerizas et al., 21
2009). 22
TFs can be thought of as "readers" of enhancers, with the combination (and spacing) of encoded 1 TFBSs defining combinatorial binding capacity and stability. TF binding may directly activate or 2 repress an enhancer and/or gene promoter, through recruitment of co-activators or co-repressors, or 3 may act indirectly to influence gene expression such as through histone displacement ( Figure 1B) . 4 The multi-protein complex Mediator is an important enhancer co-activator, which is thought to 5 coordinate enhancer-promoter interactions and stimulate transcription (Malik and Roeder, 2010) . 6
TFs may also recruit other co-activators, such as histone methyltransferases, histone 7 acetyltransferases, and chromatin-modifying complexes (Kouzarides, 2007) . By contrast, enhancers 8
and genes become repressed through TF recruitment of co-repressors such as histone demethylases 9 (Whyte et al., 2012), histone deacetylases (HDACS), and polycomb complexes (Reynolds et al., 10
2013). 11 12
TFs have the ability to directly regulate their own expression through binding to enhancer(s) that 13 control their own gene transcription. This can be thought of as a simple molecular circuit, a 14 feedback loop. By understanding the concept that a TF can regulate its own expression, and 15 expression of other TFs, it is possible to envisage the resulting TF circuits and networks that may be 16 active within mammalian cells (Davidson, 2010) . TF proteins, their genes and enhancers can be 17 considered as the building blocks or constituents of a complex TF network (Alon, 2007) . However, 18 such a TF network is commonly not active in its entirety, but instead exists in various network 19 states, comprising of active TF sub-networks. Of course, TFs not only regulate the transcription of 20 TF genes, but also of genes involved in cellular structure/function. Therefore, the TF network state 21 determines the global transcriptional program and the cell-type specific gene expression patterns 22 that define cell identity and function. genetic deletion and transcriptional activation/repression. As with any screening method, it will be 9 important to develop appropriate readouts and/or reporters for these assays. However, such tools are 10 poised to provide significant insights into enhancer regulation and TF network interactions within 11 mammalian cell types. analysis of endogenous enhancers, rather than the traditional reliance on heterologous enhancer 17 reporter assays. Large-scale application of these CRISPR/Cas9 methods is likely to provide 18 important fundamental insights into TF network architecture and principles. 19 
20

Single cell transcriptomics 21
Fluorescent-Activated Cell Sorting (FACS) has long been used to purify single cells (Osawa et al., 22 1996) , and has highlighted functional variability in highly purified cell populations (Yamamoto et 23 al., 2013 it is worth noting that live cell imaging methods are currently limited in the number of TFs that can 11 be simultaneous detected (due to fluorescent spectral overlap). However, it is clear such powerful 12 approaches are providing important quantitative insights into TF network biology. 13 
14
Open questions and future directions 15
As described above, recent technical advances are helping to drive forward our characterization of 16 mammalian TF regulatory networks. However, many of these technologies are yet to reach their full 17 potential. Several key questions remain open. We hope that these technologies and others will be 18 able to provide answers in the future. 
Dynamic modeling of a comprehensive TF network 8
While several in silico computational modeling methods have been used to study TF networks, these 9 have so far largely failed to accurately predict biological systems. More complex modeling 10 approaches are needed to better predict and extract the biological logic of TF networks. Here, it will 11 be important to move from static models to dynamic models of TF regulatory networks, which 12 better reflect biological complexity. In silico models of mammalian TF networks have also so far 13 
General principles in mammalian TF network biology 24
While many general principles that govern mammalian gene expression, enhancer activity, and TF 1 interactions, have been described, we still have few general principles that hold for explaining 2 mammalian TF networks. We hope that through integrating the above technologies, along with 3 others, we will soon start to be able to develop meaningful principles that govern this key biological 4 decision-making process. 5 6
Applications of TF network biology 7
Understanding the human TF regulatory network has important implications for health and disease. 8
These include improving disease diagnosis and developing new therapeutic strategies, as outlined 9
below. 10 11
Disease diagnosis 12
Central to the realization of personalized medicine is the ability to discriminate whether a patient 13 will respond to a particular treatment or develop resistance, will relapse or go into remission, etc. 14 Accurate biomarkers are key to this predict power. TF network components are often mutated in 15 cancers (see Box 3), but genetic mutations alone often fail to accurately predict disease progression. 16
Understanding the TF network states associated with a certain disease, and unique output (e.g. gene (and specific to) human diseases also has significant potential in identifying novel therapeutic 22
targets. 23 24
Cellular engineering 1
Reprogramming, forward programming, and trans-differentiation approaches hold important 2 promise for regenerative medicine (Graf and Enver, 2009). However, the generation of 3 transplantation-grade cells is a major hurdle for the clinical application of these approaches. TFs are 4 most commonly used in these approaches, with the best combinations of TFs being identified from 5 experimental screening. However, such approaches are often expensive, time-consuming and fail to 6 generate fully functional cell types. Several network biology-based bioinformatics tools have been 7 developed to predict TF combinations optimal for reprogramming and trans-differentiation, such as 
16
To define mammalian TF networks, we must be able to identify its constituents and understand its underlying 
6
Defining TFBSs: TF DNA-binding specificity can be determined by in vitro assays such as electrophoretic 
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